CNS Treatment Developer Supernus Pharma (SUPN) Lowers IPO Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 39.77 +1.89 (4.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.88 | 52 Week High | $26.84 | |||
| Open | $37.77 | 52 Week Low | $9.51 | |||
| Day High | $40.52 | P/E | N/A | |||
| Day Low | $37.77 | EPS | $-2.62 | |||
| Volume | 1,105,192 | |||||
